Assessment Of Efficacy and Safety UK-390,957 In Men With Premature Ejaculation

Pfizer

Status and phase: Completed; Phase 3; Phase 2

Conditions: Ejaculation

Treatments: Drug: UK-390,957

Study type: Interventional

Funder types: Industry

Identifiers

NCT00219635

A3871029

Details and patient eligibility

About

Assessment of efficacy and safety UK-390,957

Sex: Male

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Premature ejaculation as defined by DSM-IV

Exclusion criteria

• History of erectile dysfunction

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind